annual D&A:
$540.00K+$18.00K(+3.45%)Summary
- As of today (September 19, 2025), VRDN annual depreciation & amortization is $540.00 thousand, with the most recent change of +$18.00 thousand (+3.45%) on December 31, 2024.
- During the last 3 years, VRDN annual D&A has risen by +$420.00 thousand (+350.00%).
- VRDN annual D&A is now at all-time high.
Performance
VRDN Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$113.00K-$4000.00(-3.42%)Summary
- As of today (September 19, 2025), VRDN quarterly depreciation & amortization is $113.00 thousand, with the most recent change of -$4000.00 (-3.42%) on June 30, 2025.
- Over the past year, VRDN quarterly D&A has dropped by -$29.00 thousand (-20.42%).
- VRDN quarterly D&A is now -82.12% below its all-time high of $632.00 thousand, reached on December 31, 2021.
Performance
VRDN quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$483.00K-$29.00K(-5.66%)Summary
- As of today (September 19, 2025), VRDN TTM depreciation & amortization is $483.00 thousand, with the most recent change of -$29.00 thousand (-5.66%) on June 30, 2025.
- Over the past year, VRDN TTM D&A has dropped by -$489.00 thousand (-50.31%).
- VRDN TTM D&A is now -63.46% below its all-time high of $1.32 million, reached on December 31, 2023.
Performance
VRDN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
VRDN Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.5% | -20.4% | -50.3% |
| 3 y3 years | +350.0% | -56.0% | -36.4% |
| 5 y5 years | +87.5% | +1127.3% | +75.0% |
VRDN Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +350.0% | -73.8% | at low | -63.5% | +4.5% |
| 5 y | 5-year | at high | +350.0% | -82.1% | +141.8% | -63.5% | +1171.0% |
| alltime | all time | at high | +350.0% | -82.1% | +141.8% | -63.5% | +1234.3% |
VRDN Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $113.00K(-3.4%) | $483.00K(-5.7%) |
| Mar 2025 | - | $117.00K(-4.9%) | $512.00K(-5.2%) |
| Dec 2024 | $540.00K(+3.4%) | $123.00K(-5.4%) | $540.00K(-29.6%) |
| Sep 2024 | - | $130.00K(-8.5%) | $767.00K(-21.1%) |
| Jun 2024 | - | $142.00K(-2.1%) | $972.00K(-23.0%) |
| Mar 2024 | - | $145.00K(-58.6%) | $1.26M(-4.5%) |
| Dec 2023 | $522.00K(+104.7%) | $350.00K(+4.5%) | $1.32M(+36.0%) |
| Sep 2023 | - | $335.00K(-22.5%) | $972.00K(+52.6%) |
| Jun 2023 | - | $432.00K(+110.7%) | $637.00K(+37.9%) |
| Mar 2023 | - | $205.00K(-20.2%) | $462.00K(-39.1%) |
| Dec 2022 | $255.00K(+112.5%) | - | - |
| Jun 2022 | - | $257.00K(+83.6%) | $759.00K(+4.4%) |
| Mar 2022 | - | $140.00K(-77.8%) | $727.00K(+17.3%) |
| Dec 2021 | $120.00K(-49.8%) | $632.00K(-334.1%) | $620.00K(+1531.6%) |
| Sep 2021 | - | -$270.00K(-220.0%) | $38.00K(-89.6%) |
| Jun 2021 | - | $225.00K(+581.8%) | $365.00K(+182.9%) |
| Mar 2021 | - | $33.00K(-34.0%) | $129.00K(-46.0%) |
| Dec 2020 | $239.00K(-17.0%) | $50.00K(-12.3%) | $239.00K(-8.8%) |
| Sep 2020 | - | $57.00K(-618.2%) | $262.00K(-5.1%) |
| Jun 2020 | - | -$11.00K(-107.7%) | $276.00K(-22.9%) |
| Mar 2020 | - | $143.00K(+95.9%) | $358.00K(+24.3%) |
| Dec 2019 | $288.00K | $73.00K(+2.8%) | $288.00K(-0.7%) |
| Sep 2019 | - | $71.00K(0.0%) | $290.00K(+1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $71.00K(-2.7%) | $287.00K(+0.7%) |
| Mar 2019 | - | $73.00K(-2.7%) | $285.00K(+1.4%) |
| Dec 2018 | $281.00K(-8.8%) | $75.00K(+10.3%) | $281.00K(-2.1%) |
| Sep 2018 | - | $68.00K(-1.4%) | $287.00K(-3.7%) |
| Jun 2018 | - | $69.00K(0.0%) | $298.00K(-2.0%) |
| Mar 2018 | - | $69.00K(-14.8%) | $304.00K(-1.3%) |
| Dec 2017 | $308.00K(+63.0%) | $81.00K(+2.5%) | $308.00K(-2.2%) |
| Sep 2017 | - | $79.00K(+5.3%) | $315.00K(-20.1%) |
| Jun 2017 | - | $75.00K(+2.7%) | $394.00K(+7.4%) |
| Mar 2017 | - | $73.00K(-17.0%) | $367.00K(+7.6%) |
| Dec 2016 | $189.00K(+2.7%) | $88.00K(-44.3%) | $341.00K(+13.7%) |
| Sep 2016 | - | $158.00K(+229.2%) | $300.00K(+58.7%) |
| Jun 2016 | - | $48.00K(+2.1%) | $189.00K(+1.6%) |
| Mar 2016 | - | $47.00K(0.0%) | $186.00K(+1.1%) |
| Dec 2015 | $184.00K(+27.8%) | $47.00K(0.0%) | $184.00K(+5.4%) |
| Sep 2015 | - | $47.00K(+4.4%) | $174.60K(+8.0%) |
| Jun 2015 | - | $45.00K(0.0%) | $161.70K(+38.6%) |
| Mar 2015 | - | $45.00K(+19.7%) | $116.70K(+62.8%) |
| Dec 2014 | $144.00K(-2.7%) | $37.60K(+10.3%) | $71.70K(+1.7%) |
| Sep 2014 | - | $34.10K(-6.3%) | $70.50K(+93.7%) |
| Dec 2013 | $148.00K(+2.6%) | $36.40K(+0.6%) | $36.40K(+0.6%) |
| Dec 2012 | $144.30K | - | - |
| Dec 2012 | - | $36.20K | $36.20K |
FAQ
- What is Viridian Therapeutics, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual D&A year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Viridian Therapeutics, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. TTM D&A year-on-year change?
What is Viridian Therapeutics, Inc. annual depreciation & amortization?
The current annual D&A of VRDN is $540.00K
What is the all time high annual D&A for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual depreciation & amortization is $540.00K
What is Viridian Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, VRDN annual depreciation & amortization has changed by +$18.00K (+3.45%)
What is Viridian Therapeutics, Inc. quarterly depreciation & amortization?
The current quarterly D&A of VRDN is $113.00K
What is the all time high quarterly D&A for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly depreciation & amortization is $632.00K
What is Viridian Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, VRDN quarterly depreciation & amortization has changed by -$29.00K (-20.42%)
What is Viridian Therapeutics, Inc. TTM depreciation & amortization?
The current TTM D&A of VRDN is $483.00K
What is the all time high TTM D&A for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high TTM depreciation & amortization is $1.32M
What is Viridian Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, VRDN TTM depreciation & amortization has changed by -$489.00K (-50.31%)